summari opportun meet
 treasur duncan vice-president investor relat administr
part west coast bu tour manag sound upbeat
outlook continu growth momentum contact
len market coopervis strong competit posit
turnaround csi coopersurg key take-away
includ manag seem confid outlook continu
anticip tax rate increas contact len market continu
grow forese futur seem well
posit gain share manag particularli excit
long-term prospect myopia manag lens csi
enter period consist perform
increas price target base
manag sound confid outlook
meet manag seem confid guidanc
outlook continu mid- high-singl digit growth
low- mid-singl growth csi particular
manag sound optimist contact len market
growth momentum continu forese futur
compani well posit continu take share
thu outperform market csi anniversari exit
gener test busi complet integr recent
acquisit well addit paragard drive
consist growth bottom-lin manag focu
underli ex-fx margin improv debt pay
optim tax rate help deliv guidanc ep
growth exclud fx estim oper margin wouldv
exceed yr/yr ep growth would
guidanc impli slower growth recal
guid pro forma sale growth impli
growth vs deceler reflect tougher
prior year comp guidanc includ growth
csi growth impli growth vs
csi growth vs sale
grew nearli vs nearli make
yr/yr comparison challeng especi
anticip deceler csi reflect potenti disrupt
continu product transfer new costa rica plant like
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
continu previou page
potenti benefit japan stock exclud guidanc japan due rais
consumpt tax base histori expect buy-in
ahead tax increas would benefit sale end octob confirm
inventori benefit ahead last consumpt tax increas benefit
revers subsequ quarter expect benefit year revers
know magnitud stock benefit last time around note japan
repres two-third cvi apac sale apac sale total
expect ep growth acceler despit higher tax rate yet give
guidanc manag state target double-digit ex-fx oper incom growth next
year believ realist given growth outlook busi anticip margin
improv product mix increas effici bottom-lin math suggest
ep growth may realist despit anticip hike tax rate current anticip
tax rate increas year next year howev compani initi
guid tax rate declin guidanc base one-tim
restructur benefit benefit stock-bas compens could see
tax rate base stock-bas comp benefit addit increas focu
pay debt given strong free cash-flow suggest interest expens could fall
year closer next year estim could boost bottom-lin growth
put togeth believ realist deliveri ep growth exclud
currenc impact updat model interest expens tax rate forecast
ep growth slightli consensu growth
seem contact len market continu grow estim global contact
len market grow mid- high-singl digit rang past year manag
believ market growth sustain forese futur continu
convers daili lens upgrad silicon hydrogel sihi materi compani estim
move daili repres increas revenu per patient upgrad sihi materi
add premium addit believ entri new sihi daili product
alc precis bhc aqualox support continu move sihi daili thu help
boost overal market growth estim sihi account non-daili segment
believ sihi percent daili segment approach number long run vs current
believ well posit outpac market growth given exposur sihi daili
current hold share global contact len market tie alc spot daili
repres dollar market wearer grow trail
month ttm faster overal market ttm growth although under-index
overal daili market share busi over-index share sihi daili
segment grew ttm see figur even anticip competit alc precis
bhc aqualox next year manag believ continu grow share
segment myday clariti specif manag believ competit launch may
take longer time ramp manufactur capac could rate limit factor potenti impact
late non-sihi daili segment remain under-index estim
share non-daili contact len market note segment return low-singl
digit growth longer declin hold market within non-daili compani
see biofin monthli franchis perform better avaira portfolio consist
overal monthli vs market perform
figur over-index grow sihi daili market
manag excit opportun myopia manag call
disclos specialti len sale run sale annual grow
sustain time compani start increas product invest
behind misight contact len myopia manag ou market
discuss fda regard us regulatori pathway manag seem optimist
year misight data would use toward fda approv busi current modest size
opportun signific long run growth margin accret time
csi perform consist current portfolio last coupl year csi
perform mostli disappoint due part on-going integr acquisit price
pressur market like genet test etc headwind larg rearview mirror
manag seem cautious optimist csi growth ahead consist in-lin
market manag see office/surg busi grow in-lin market
low-singl digit paragard grow mid-singl digit potenti better base recent perform
stronger growth ivf fertil busi given csi posit said csi
invest capit expenditur move product new plant costa rica could caus
near-term disrupt continu see signific opportun paragard growth
iud intrauterin devic market still invest behind product
billion cl marketttm growth sale growth sihi sihi cl market cl market compani report secur llc estim repres averag last four quarter frp frequent replac contact lens daili figur ital repres calcul medic technolog
price target
price target base ep estim risk includ slower growth
contact len market increas competit stronger dollar
particip attract contact len market sale grow
strong portfolio lens across modal help compani continu take share
global medic devic compani develop manufactur market health care
product two divis coopervis produc contact lens account
revenu coopersurg women health busi contribut nearli revenu
coopervis tie player nearli share billion global soft contact len
market revenu grew pro forma billion million
